Table 1. Patients’ characteristics
Characteristics | Patients (n = 11) |
|---|---|
Age, years, mean (range) | 64 (57–72) |
Male sex, n (%) | 7 (63.6) |
Etiology of cirrhosis | |
Alcohol, n (%) | 9 (81.8) |
NASH, n (%) | 1 (9.1) |
Other, n (%) | 1 (9.1) |
Severity and complication of cirrhosis | |
MELD-score | 20 (± 9) |
Child Pugh B, n (%) | 3 (27.3) |
Child Pugh C, n (%) | 8 (72.7) |
Esophageal varices, n (%) | 5 (45.5) |
Prior gastrointestinal bleeding, n (%) | 3 (27.3) |
Prior hepatic encephalopathy n (%) | 1 (9.1) |
Prior hepatorenal syndrome, n (%) | 1 (9.1) |
Primary SBP prophylaxis, n (%) | 6 (54.5) |
Fluoroquinolones used for prophylaxis | |
Norfloxacin, n (%) | 8 (72.7) |
Ciprofloxacin, n (%) | 3 (27.3) |
Concomitant medication | |
Beta-blocker, n (%) | 6 (54.5) |
Proton-pump inhibitors, n (%) | 7 (63.6) |
Laboratory results | |
C-reactive protein (mg/dL) | 2.9 (± 2.7) |
White blood count (/nL) | 7.8 (± 3.0) |
Bilirubin (mg/dL) | 5.9 (± 6.5) |
Alanine aminotransferase (U/L) | 40 (± 37) |
International normalized ratio | 1.8 (± 0.5) |
Creatinine (mg/dL) | 1.5 (± 0.9) |
Albumin (g/dL) | 3.2 (± 1.5) |